Octapharma
Austria - ViennaPharmaceutical
Focus: Octapharma is an Austria-based plasma-derived pharmaceutical company with 5,000+ employees specializing in immunoglobulins, coagulation factors, and albumin products for rare bleeding and immune disorders. The company operates as a mature specialty pharma player with a highly concentrated revenue base driven by peak-stage products.
Profile data last refreshed 22h ago · AI intelligence enriched 3w ago
Funding Stage
SERIES A
Employees
5000+
Open Jobs
0
About Octapharma
AI assessmentNot HiringNo open roles listed right now. Follow Octapharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Octapharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
14 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$34M Part DStable
Peak
Anchor product generating 95% of company revenue; BLA-approved intravenous immunoglobulin with broad rare disease applications.
Help build intelligence for Octapharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.